Dame Kate Bingham Celebrates 'Astonishing' $3bn Deal for EyeBio
London-based biotech company EyeBio, co-founded by Dame Kate Bingham, sold to Merck for up to $3bn, promising revolutionary treatments for blindness.
Source: bmmagazine.co.uk
Page 2 - David Guyer News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from David Guyer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In David Guyer Today - Breaking & Trending Today
Merck to acquire EyeBio in potential $3B deal
The privately held ophthalmology-focused biotechnology company focuses on the treatment of vision loss associated with retinal vascular leakage.
Source: njbiz.com
Merck acquires ophthalmology startup EyeBio
By scooping up EyeBio, Merck is expanding its ophthalmology offerings and bolstering its vision care pipeline.
Source: mmm-online.com
Merck has clear vision to eye disease assets with $3B EyeBio buy
Merck & Co. is focusing in on eye diseases with the $3 billion acquisition of ophthalmology-focused Eyebiotech.
Source: fiercebiotech.com